130 related articles for article (PubMed ID: 11710996)
21. A recombinant human interferon-alpha B/D hybrid with a broad host-range.
Horisberger MA; de Staritzky K
J Gen Virol; 1987 Mar; 68 ( Pt 3)():945-8. PubMed ID: 3029315
[TBL] [Abstract][Full Text] [Related]
22. Mode of selection and experimental evolution of antiviral drugs resistance in vesicular stomatitis virus.
Cuevas JM; Sanjuán R; Moya A; Elena SF
Infect Genet Evol; 2005 Jan; 5(1):55-65. PubMed ID: 15567139
[TBL] [Abstract][Full Text] [Related]
23. The biological effects of five feline IFN-alpha subtypes.
Baldwin SL; Powell TD; Sellins KS; Radecki SV; Cohen JJ; Milhausen MJ
Vet Immunol Immunopathol; 2004 Jun; 99(3-4):153-67. PubMed ID: 15135982
[TBL] [Abstract][Full Text] [Related]
24. Effect of amino acids on the expression of antiviral activity of different types of human interferon. II. Effects of various amino acid pairs.
Tóth S; Mécs I
Acta Microbiol Hung; 1985; 32(4):369-72. PubMed ID: 3012930
[TBL] [Abstract][Full Text] [Related]
25. [Antiviral properties of recombinant human lymphotoxin].
Denisov AA; Nikolaeva OG
Vopr Virusol; 1995; 40(6):277-9. PubMed ID: 8686267
[TBL] [Abstract][Full Text] [Related]
26. Thyroid hormone potentiates the antiviral action of interferon-gamma in cultured human cells.
Lin HY; Thacore HR; Davis PJ; Davis FB
J Clin Endocrinol Metab; 1994 Jul; 79(1):62-5. PubMed ID: 8027254
[TBL] [Abstract][Full Text] [Related]
27. Potentiating effect of murine interferon-gamma-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-alpha/beta: identification of the potentiation factor as murine interferon-gamma itself.
Fleischmann WR; Fleischmann CM
Antiviral Res; 1984 Aug; 4(4):221-8. PubMed ID: 6091541
[TBL] [Abstract][Full Text] [Related]
28. Antitumor, antiviral and natural killer-inducing activities of human recombinant interferon-alpha in the guinea pig.
Kataoka T; Ishitsuka H; Tokunaga T
Jpn J Med Sci Biol; 1986 Apr; 39(2):97-103. PubMed ID: 3022044
[TBL] [Abstract][Full Text] [Related]
29. Biologic activities of natural and synthetic type I interferons.
Pfeffer LM
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
[TBL] [Abstract][Full Text] [Related]
30. [How to make an ally of an "inactive" product: the example of interferon].
Lavelle F
Bull Cancer; 2000 Sep; 87(9):621-2. PubMed ID: 11184449
[No Abstract] [Full Text] [Related]
31. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
[TBL] [Abstract][Full Text] [Related]
32. Human interferon and cell growth inhibition. VII. Reversibility of interferon activities.
Dahl H
J Interferon Res; 1983; 3(4):387-93. PubMed ID: 6323590
[TBL] [Abstract][Full Text] [Related]
33. Cloning, expression and antiviral bioactivity of red-crowned crane interferon-α.
Tian L; Zhao P; Ma B; Guo G; Sun Y; Xing M
Gene; 2014 Jul; 544(1):49-55. PubMed ID: 24768181
[TBL] [Abstract][Full Text] [Related]
34. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules.
Schmeisser H; Hu R; Kontsek P; Bekisz J; Zoon K
J Interferon Cytokine Res; 2002 Apr; 22(4):463-72. PubMed ID: 12034029
[TBL] [Abstract][Full Text] [Related]
35. Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells.
Schijns VE; Van der Neut R; Haagmans BL; Bar DR; Schellekens H; Horzinek MC
J Gen Virol; 1991 Apr; 72 ( Pt 4)():809-15. PubMed ID: 1849968
[TBL] [Abstract][Full Text] [Related]
36. Antiviral and antiproliferative activities of human leukocyte interferon potentiated by cimetidine in vitro.
Hirai N; Hill NO; Motoo Y; Osther K
J Interferon Res; 1985; 5(3):375-82. PubMed ID: 2997335
[TBL] [Abstract][Full Text] [Related]
37. [Properties of human alpha-interferon F and hybrid interferon F/D obtained from recombinant bacteria compared to the properties of an interferon preparation from human leukocytes].
Ovchinnikov IuA; Sverdlov ED; Tsarev SA; Monastyrskaia GS; Khodkova EM
Dokl Akad Nauk SSSR; 1983; 268(4):996-1000. PubMed ID: 6187523
[No Abstract] [Full Text] [Related]
38. Purification of recombinant human interferon-epsilon and oligonucleotide microarray analysis of interferon-epsilon-regulated genes.
Peng FW; Duan ZJ; Zheng LS; Xie ZP; Gao HC; Zhang H; Li WP; Hou YD
Protein Expr Purif; 2007 Jun; 53(2):356-62. PubMed ID: 17287131
[TBL] [Abstract][Full Text] [Related]
39. Antiviral and antitumor effects of a human interferon analog, IFN-alpha Con 1, assessed in hamsters.
Altrock BW; Fagin KD; Hockman HR; Fish EN; Goldstein L; Chang D; Duker K; Stebbing N
J Interferon Res; 1986 Aug; 6(4):405-15. PubMed ID: 3021874
[TBL] [Abstract][Full Text] [Related]
40. Molecular and biologic characterization of recombinant interferon-alpha2b.
Bordens R; Grossberg SE; Trotta PP; Nagabhushan TL
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-41-S9-51. PubMed ID: 9208872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
